Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype.

Crews KR, Gaedigk A, Dunnenberger HM, Klein TE, Shen DD, Callaghan JT, Kharasch ED, Skaar TC; Clinical Pharmacogenetics Implementation Consortium..

Clin Pharmacol Ther. 2012 Feb;91(2):321-6. doi: 10.1038/clpt.2011.287. Epub 2011 Dec 28.

2.

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.

Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, Anderson JL, Kimmel SE, Lee MT, Pirmohamed M, Wadelius M, Klein TE, Altman RB; Clinical Pharmacogenetics Implementation Consortium..

Clin Pharmacol Ther. 2011 Oct;90(4):625-9. doi: 10.1038/clpt.2011.185. Epub 2011 Sep 7. Review.

3.

Behavioral and pharmacogenetics of aggressive behavior.

Takahashi A, Quadros IM, de Almeida RM, Miczek KA.

Curr Top Behav Neurosci. 2012;12:73-138. Review.

4.

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Camilleri M, Katzka DA.

Am J Physiol Gastrointest Liver Physiol. 2012 May 15;302(10):G1075-84. doi: 10.1152/ajpgi.00537.2011. Epub 2012 Mar 8. Review.

5.

Clinical application of cardiovascular pharmacogenetics.

Voora D, Ginsburg GS.

J Am Coll Cardiol. 2012 Jul 3;60(1):9-20. doi: 10.1016/j.jacc.2012.01.067. Review.

6.

Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.

King DP, Paciga S, Pickering E, Benowitz NL, Bierut LJ, Conti DV, Kaprio J, Lerman C, Park PW.

Neuropsychopharmacology. 2012 Feb;37(3):641-50. doi: 10.1038/npp.2011.232. Epub 2011 Nov 2.

7.

Pharmacogenetics of cutaneous adverse drug reactions.

Aihara M.

J Dermatol. 2011 Mar;38(3):246-54. doi: 10.1111/j.1346-8138.2010.01196.x. Review.

PMID:
21342226
8.

Drug hypersensitivity: pharmacogenetics and clinical syndromes.

Phillips EJ, Chung WH, Mockenhaupt M, Roujeau JC, Mallal SA.

J Allergy Clin Immunol. 2011 Mar;127(3 Suppl):S60-6. doi: 10.1016/j.jaci.2010.11.046.

9.

Personalizing medicine with clinical pharmacogenetics.

Scott SA.

Genet Med. 2011 Dec;13(12):987-95. doi: 10.1097/GIM.0b013e318238b38c. Review.

10.

Pharmacogenetics of antidepressive drugs: a way towards personalized treatment of major depressive disorder.

Weizman S, Gonda X, Dome P, Faludi G.

Neuropsychopharmacol Hung. 2012 Jun;14(2):87-101. Review.

11.

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.

Scott SA, Sangkuhl K, Gardner EE, Stein CM, Hulot JS, Johnson JA, Roden DM, Klein TE, Shuldiner AR; Clinical Pharmacogenetics Implementation Consortium..

Clin Pharmacol Ther. 2011 Aug;90(2):328-32. doi: 10.1038/clpt.2011.132. Epub 2011 Jun 29. Review. No abstract available.

12.

Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics.

Ellingrod VL, Taylor SF, Dalack G, Grove TB, Bly MJ, Brook RD, Zöllner SK, Pop-Busui R.

J Clin Psychopharmacol. 2012 Apr;32(2):261-5. doi: 10.1097/JCP.0b013e3182485888.

13.

Pharmacogenetics of opioids for the treatment of acute maternal pain during pregnancy and lactation.

Madadi P, Avard D, Koren G.

Curr Drug Metab. 2012 Jul;13(6):721-7. Review.

PMID:
22452458
14.

Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Stehle S, Kirchheiner J, Lazar A, Fuhr U.

Clin Pharmacokinet. 2008;47(9):565-94. Review.

PMID:
18698879
15.

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.

Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Müller DJ.

Mol Psychiatry. 2012 Mar;17(3):242-66. doi: 10.1038/mp.2011.109. Epub 2011 Sep 6. Review.

PMID:
21894153
16.

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.

Narasimhan S, Lohoff FW.

Pharmacogenomics. 2012 Mar;13(4):441-64. doi: 10.2217/pgs.12.1. Review.

PMID:
22380000
17.

Pharmacogenetics: from bench to byte--an update of guidelines.

Swen JJ, Nijenhuis M, de Boer A, Grandia L, Maitland-van der Zee AH, Mulder H, Rongen GA, van Schaik RH, Schalekamp T, Touw DJ, van der Weide J, Wilffert B, Deneer VH, Guchelaar HJ.

Clin Pharmacol Ther. 2011 May;89(5):662-73. doi: 10.1038/clpt.2011.34. Epub 2011 Mar 16. Review.

PMID:
21412232
18.

Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease.

Kalinderi K, Fidani L, Katsarou Z, Bostantjopoulou S.

Int J Clin Pract. 2011 Dec;65(12):1289-94. doi: 10.1111/j.1742-1241.2011.02793.x. Review.

PMID:
22093536
19.
20.

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.

Relling MV, Gardner EE, Sandborn WJ, Schmiegelow K, Pui CH, Yee SW, Stein CM, Carrillo M, Evans WE, Klein TE; Clinical Pharmacogenetics Implementation Consortium..

Clin Pharmacol Ther. 2011 Mar;89(3):387-91. doi: 10.1038/clpt.2010.320. Epub 2011 Jan 26. Erratum in: Clin Pharmacol Ther. 2011 Dec;90(6):894.

Supplemental Content

Support Center